Grown Rogue International (GRUSF) EPS (Basic) Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) EPS (Basic) Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -220.62% |
| Jul 31, 2023 | 29.22% |
| Apr 30, 2023 | 29.48% |
| Jan 31, 2023 | 31.01% |
| Jan 31, 2022 | 68.00% |
| Jul 31, 2021 | 90.48% |
| Apr 30, 2021 | 60.58% |
| Jan 31, 2021 | 61.38% |
| Aug 31, 2018 | -43.53% |
| May 31, 2018 | 11,585.70% |
| Feb 28, 2018 | -25,176.94% |
| Nov 30, 2017 | 29,061.08% |
| Aug 31, 2017 | -1,304.18% |
| May 31, 2017 | 98.67% |
| Feb 28, 2017 | 25.99% |
| Aug 31, 2016 | 1,713.56% |
| Feb 29, 2016 | 25.99% |
| Aug 31, 2015 | 824.59% |
| May 31, 2015 | 25.99% |
| Feb 28, 2015 | 25.99% |